Stereotactic and Needle Breast Biopsy


4.4 out of 5 (43 Reviews)



Post Assessment Questions


Start Date

1 Sep 2023

Last Review Date

21 Apr 2024

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes

Need Help?  If you have a system or content concerns, please contact

Activity Description

Globally, over 2 million new cases of breast cancer were diagnosed in women in 2020, and breast cancer remains the second most common cause of cancer-related deaths. In the United States, breast cancer accounts for 30% of new yearly cancer diagnoses in women. However, the mortality from breast cancer has been declining due to improved detection and advanced treatments. Vigorous screening and sophisticated diagnostic techniques increase the detection of occult breast cancer. This activity delves into the current standards of image-guided biopsies, emphasizing ultrasound, mammography, and magnetic resonance techniques. The advantages and disadvantages of the procedure are highlighted.

This course empowers clinicians to enhance diagnostic accuracy and improve the management of breast cancer by elucidating the interplay between imaging equipment, tissue sampling devices, and biopsy guidance modalities. Participants will gain proficiency in applying various tissue sampling devices, including fine needle aspiration, vacuum-assisted biopsy, and spring-loaded core needle biopsy devices. Interprofessional collaboration among primary care clinicians and treating surgeons is emphasized for positive postoperative outcomes.

Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Apply knowledge of fine-needle aspiration, vacuum-assisted core biopsy, and spring-loaded core needle biopsy devices to select the best approach based on clinical presentation.

  • Differentiate between biopsy techniques, including ultrasound-guided, mammography-guided, and magnetic resonance-guided approaches.

  • Identify appropriate candidates for stereotactic and needle breast biopsies based on clinical indications.

  • Collaborate with interdisciplinary teams for comprehensive cancer care in testing patients with stereotactic and needle breast biopsy.


StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.


Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.50 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Anesthesiology: This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website,, for a list of all MOCA 2.0 requirements.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.50 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact


This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.





helene C. on 12/17/2020

Thomas P. on 9/13/2021

Megan F. on 10/4/2021

Paula N. on 11/26/2021

Karlin S. on 12/1/2021

Laura B. on 12/13/2021

Richard H. on 7/31/2022

Bernadette G. on 9/6/2022

Stephanie Y. on 12/16/2022

I disagree with the answer for the example of the female with a breast abnormality and obvious abnormal ultrasound finding of vertical irregular mass. I believe the abnormal ultrasound warrants immediate ultrasound guided biopsy and 3 month follow-up is not warranted which delays diagnosis as well as risk noncompliance of patient with delayed follow-up visit in a timely manner.

DR N. on 1/5/2023

Nicole H. on 1/23/2023

Clark P. on 2/8/2023

Josh P. on 4/1/2023

Catherine O. on 4/11/2023

Malcolm B. on 4/12/2023

Aseeb R. on 4/17/2023

Stacey O. on 7/4/2023


RAQUEL . on 7/28/2023

Tiffany B. on 8/26/2023

Ron H. on 9/27/2023

Jennifer T. on 9/27/2023

Katherine C. on 10/8/2023

Laura G. on 10/18/2023

Melissa T. on 11/1/2023

Sarah R. on 11/7/2023

Silas W. on 12/9/2023

christine b. on 12/15/2023

Julie D. on 12/26/2023

Mary H. on 12/29/2023

Jovelie D. on 12/30/2023

MARIA F. on 12/30/2023

Jami S. on 12/31/2023

Jonathan W. on 1/14/2024

Great review.

Richard P. on 2/25/2024

Lisa R. on 2/28/2024

Silas W. on 2/29/2024

Mark A. on 3/16/2024

Elizabeth B. on 3/19/2024

Sharifa N. on 3/23/2024

DEAN E. on 4/3/2024

Stacy T. on 4/6/2024

Jessica B. on 4/13/2024

Lesley M. on 6/4/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6673 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7923.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user